Shelley Kim Fraser
No más puestos en curso
Perfil
Shelley Kim Fraser worked as a Secretary & Finance Director at hVIVO Ltd.
in 2019.
She also worked as a Finance Director at Organon Pharma (UK) Ltd.
Additionally, she served as the Chief Financial Officer & Director at Induction Healthcare Group Plc from 2019 to 2021.
Antiguos cargos conocidos de Shelley Kim Fraser.
| Empresas | Cargo | Fin |
|---|---|---|
| INDUCTION HEALTHCARE GROUP PLC | Director Financiero/CFO | 19/01/2021 |
| HVIVO PLC | Director Financiero/CFO | 31/07/2019 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Director Financiero/CFO | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INDUCTION HEALTHCARE GROUP PLC | Technology Services |
| Empresas privadas | 2 |
|---|---|
hVIVO Ltd.
 hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Shelley Kim Fraser
